Company Search:
Advanced Search
Sponsored Links
BioPorto A/S Company Snapshot
BioPorto A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioPorto A/S with three other pharmaceutical manufacturers in Europe: Biocorp Sa of France (2016 sales of 2.95 million Euro [US$3.47 million] ), Premier Veterinary Group PLC of the United Kingdom (£2.99 million [US$4.00 million] ), and Collagen Solutions PLC which is also based in the United Kingdom (£3.13 million [US$4.19 million] ).

Sales Analysis. BioPorto A/S reported sales of 20.72 million Danish Kroner (US$3.28 million) for the year ending December of 2016. This represents a very small increase of 1.7% versus 2015, when the company's sales were 20.38 million Danish Kroner. This was the third consecutive year of growth at BioPorto A/S.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioPorto A/S
  Stock Performance Chart for BioPorto A/S
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 3.45
(Figures in Danish Kroner)
1 Week -1.4%   13 Weeks -4.4%  
4 Weeks 6.8%   52 Weeks 101.8%  
BioPorto A/S Key Data:
  Ticker: BIOPOR Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 20,720,000
(Year Ending Jan 2017).
Employees: 27
  Currency: Danish Kroner Market Cap: 536,508,399
  Fiscal Yr Ends: December Shares Outstanding: 155,509,681
  Share Type: B Aktie Closely Held Shares: 32,061,163
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.